Esther Lange is a Business Development Manager for Viral Vector Out-licensing at Revvity. In her role, she is responsible for identifying and developing strategic partnerships for Revvity’s viral vector technologies, managing out-licensing opportunities, and building relationships with biopharmaceutical partners across global markets. Esther brings extensive experience in business development and partnership management within the cell and gene therapy (CGT) and other biotechnology sectors, where she has successfully negotiated and executed licensing agreements and strategic collaborations.